Jinxue X. Zhou - Publications

Crosstalk Between Schwann Cells and CD4+ T Cells Promotes Perineural Invasion in Colorectal Cancer.

Journal: Cancer research

Published: December 17, 2025

TREM1+ Neutrophils Determine Immunosuppressive Microenvironment and Immunotherapy Response in Hepatocellular Carcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 02, 2025

Engineered CAR-NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 28, 2025

Development of a circulating tumor DNA methylation biomarker panel for hepatocellular carcinoma detection.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 22, 2025

Corrigendum to "CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma" [Cancer Lett. 614 (2025) 217473].

Journal: Cancer letters

Published: May 11, 2025

Age-dependent prognostic significance of neutrophil-to-HDL ratio in hepatocellular carcinoma patients.

Journal: Frontiers in oncology

Published: April 30, 2025

PLAUR+ Neutrophils Drive Anti-PD-1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 21, 2025

ZFPL1 Promotes Colorectal Cancer Progression by Stabilizing ASS1 to Drive the Urea Cycle and M2 Macrophage-Mediated Metastatic Colonization.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 23, 2025

Liver sinusoidal endothelial cells in hepatic fibrosis: opportunities for future strategies.

Journal: Biochemical and biophysical research communications

Published: March 12, 2025

Metabolic dysfunction-associated steatotic liver disease increases the incidence of metachronous liver metastases from TNM stage 0-II colorectal cancer.

Journal: Hepatology international

Published: January 21, 2025

Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).

Journal: Bioscience trends

Published: December 25, 2024

Efficacy and safety of combining tislelizumab with capecitabine compared to capecitabine alone in the adjuvant treatment of biliary tract cancers: rationale and protocol design for a randomized clinical trial.

Journal: BMC cancer

Published: November 24, 2024